Sign In
to Vote &
Create Storyboards.
 
A new therapeutic vaccine, GTL001, developed to clear HPV strains 16 and 18 - the types most likely to cause cancer - is being evaluated for safety in a Phase I clinical trial.
1
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard